These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32158248)

  • 1. Reevaluation of the Efficacy of First Line Regimen for
    Tariq H; Patel H; Kamal MU; Abbas N; Ameen M; Azam S; Kumar K; Ravi M; Vootla V; Shaikh D; Amanchi V; Hussain AN; Makker J
    Clin Exp Gastroenterol; 2020; 13():25-33. PubMed ID: 32158248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis.
    Li Y; Huang X; Yao L; Shi R; Zhang G
    Wien Klin Wochenschr; 2010 Jul; 122(13-14):413-22. PubMed ID: 20628905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
    Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
    Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-line rescue treatment of
    Lin TF; Hsu PI
    World J Gastroenterol; 2018 Oct; 24(40):4548-4553. PubMed ID: 30386104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand.
    Prapitpaiboon H; Mahachai V; Vilaichone RK
    Asian Pac J Cancer Prev; 2015; 16(10):4353-6. PubMed ID: 26028098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens in
    Arj A; Mollaei M; Razavizadeh M; Moraveji A
    J Res Pharm Pract; 2020; 9(2):101-105. PubMed ID: 33102384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection.
    Gisbert JP; Perez-Aisa A; Rodrigo L; Molina-Infante J; Modolell I; Bermejo F; Castro-Fernández M; Antón R; Sacristán B; Cosme A; Barrio J; Harb Y; Gonzalez-Barcenas M; Fernandez-Bermejo M; Algaba A; Marín AC; McNicholl AG;
    Dig Dis Sci; 2014 Feb; 59(2):383-9. PubMed ID: 24126798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.
    Gisbert JP; Romano M; Gravina AG; Solís-Muñoz P; Bermejo F; Molina-Infante J; Castro-Fernández M; Ortuño J; Lucendo AJ; Herranz M; Modolell I; Del Castillo F; Gómez J; Barrio J; Velayos B; Gómez B; Domínguez JL; Miranda A; Martorano M; Algaba A; Pabón M; Angueira T; Fernández-Salazar L; Federico A; Marín AC; McNicholl AG
    Aliment Pharmacol Ther; 2015 Apr; 41(8):768-75. PubMed ID: 25703120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.
    Kahramanoğlu Aksoy E; Pirinçci Sapmaz F; Göktaş Z; Uzman M; Nazlıgül Y
    Med Princ Pract; 2017; 26(6):523-529. PubMed ID: 29131124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
    Saad RJ; Schoenfeld P; Kim HM; Chey WD
    Am J Gastroenterol; 2006 Mar; 101(3):488-96. PubMed ID: 16542284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial.
    Hsu PI; Tsai FW; Kao SS; Hsu WH; Cheng JS; Peng NJ; Tsai KW; Hu HM; Wang YK; Chuah SK; Chen A; Wu DC
    Am J Gastroenterol; 2017 Sep; 112(9):1374-1381. PubMed ID: 28719592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication.
    Gao XZ; Qiao XL; Song WC; Wang XF; Liu F
    World J Gastroenterol; 2010 Sep; 16(34):4357-62. PubMed ID: 20818821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levofloxacin-azithromycin combined triple therapy for Helicobacter pylori eradication].
    Kang MS; Park DI; Yun JW; Oh SY; Yoo TW; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2006 Jan; 47(1):30-6. PubMed ID: 16434866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori-related diseases.
    Gisbert JP
    Gastroenterol Hepatol; 2016 Sep; 39 Suppl 1():36-46. PubMed ID: 27888863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy of levofloxacin based triple therapy for Helicobacter pylori eradication].
    Lee JH; Hong SP; Kwon CI; Phyun LH; Lee BS; Song HU; Ko KH; Hwang SG; Park PW; Rim KS; Kim S
    Korean J Gastroenterol; 2006 Jul; 48(1):19-24. PubMed ID: 16861877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication.
    Schrauwen RW; Janssen MJ; de Boer WA
    Neth J Med; 2009 Mar; 67(3):96-101. PubMed ID: 19307680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.
    Su J; Zhou X; Chen H; Hao B; Zhang W; Zhang G
    Medicine (Baltimore); 2017 Feb; 96(7):e5859. PubMed ID: 28207505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levofloxacin-based triple therapy versus bismuth-based quadruple therapy in the treatment of
    Zhang M; Chen CY; Wang XT; Lyu B
    Zhonghua Nei Ke Za Zhi; 2017 May; 56(5):368-374. PubMed ID: 28460509
    [No Abstract]   [Full Text] [Related]  

  • 20. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
    Song Z; Zhou L; Zhang J; He L; Bai P; Xue Y
    Dig Liver Dis; 2016 May; 48(5):506-511. PubMed ID: 26847964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.